Take e-pledge at CVC website https://pledge.cvc.nic.in 


Advancing Cancer Immunotherapy: An Intimate Play of CD8 T and NK Cells

25 - October -2017
Duration: 14:30 PM To 15:30 PM

Venue: Seminar Hall, Main Building

A special seminar by Dr. Anil Shankar, Associate Professor of Biochemistry and Cancer Biology & Member, Vanderbilt-Ingram Cancer Center and Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University, USA. He did PhD in Biotechnology (Tumor Immunology) from Banaras Hindu University, India in 1999. Click here to know more about to Dr. Anil Shankar   Abstract: The central theme of Shanker laboratory is to develop strategies that can empower cytolytic function of lymphocytes in the battle against cancer and its relapse. In models of   Read More..

CSIR Foundation Day Celebrations

23 - November -2017
Duration: 14:30 PM To 17:30 PM

Venue: CSIR-IMTech Auditorium

CSIR Foundation Day Lectures  KEY NOTE ADDRESS “Challenges and Opportunities in Development of Biosimilar Products” by Prof. Anurag S. RathoreDepartment of Chemical EngineeringIndian Institute of Technology, New Delhi and GUEST TALK“Opportunities at the interface of Engineering and Biology” by Prof. Pramod P. WangikarDepartment of Chemical EngineeringIndian Institute of Technology, Mumbai   on November 23, 2017 at 2.30 p.m. in the IMTECH Auditorium   PROGRAMME   2.30 p.m Welcome &   Read More..

CSIR-IMTech Signs MOU With Johnson & Johnson for collaborative research on TB

16 - August -2017
Duration: 09:00 AM To 14:00 PM

Venue: CSIR New Delhi

CSIR-IMTech signed a MoU with global multinational healthcare company, Johnson & Johnson Private Limited. Honable Dr Harsh Vardhan, Ministry of Science & Technology (India), Vice President, CSIR presided over the event accompanied by Dr Girish Sahni, DG CSIR, Dr Anil Koul Director CSIR-IMTech, Dr. Paul Stoffels, Chief Scientific Officer of Johnson & Johnson and senior members of the company’s Global Public Health unit.     Read More..

Dr Paul Janssen TB Symposium on 17th August 2017.

17 - August -2017
Duration: 14:00 PM To 20:00 PM


CSIR-IMTECH focuses on cutting edge microbial science and technological research with an aim to deliver new drugs and healthcare solutions for the poorest of poor. For the same, CSIR-IMTECH is intended to enter into collaboration with global pharma giant Johnson & Johnson for development of new drugs for Tuberculosis (TB).

Dr. Wim Parys, Head of R D Global Public Health and Dr. Pierre Raboisson, Head of Infectious Diseases Research from Janssen visit at IMTECH

21 - April -2017
Duration: 14:00 PM To 17:00 PM


Discussed the challenges and solutions associated with patient care through discovery of novel antibiotics for infectious diseases. Eminent Speakers gave lectures: Global Public Health: Meeting the Challenges by Dr Wim Parys, Head of R&D Global Public Health and Drug from the Middle Space: Synthetic Macrocycles targeting Infectious Diseases by Dr Pierre Raboisson, Head of Infectious Diseases Research.   Read More..

Immunosuppression and infection

20 - November -2017
Duration: 14:15 PM To 15:45 PM

Venue: Auditorium CSIR-IMTech

A Special Seminar

IMTechCon: 3 day Industry-Academia Meet

04 - October -2017 To 06 - October -2017
Duration: 3 Days

Venue: CSIR IMTech

CSIR-IMTECH is organizing an 'Industry-Academia Meet' at IMTECH campus from 4th-6th October 2017. The aim is to get a better engagement with key industry & academic leaders and establish a platform where we can discuss the challenges of Industry and how academic/research institutions can forge new R&D partnerships and alliances.

International Yoga Day Celebrations at CSIR-IMTech

21 - June -2017
Duration: 07:00 AM To 08:00 AM

Venue: CSIR-IMTECH Ground

International Yoga Day Celebrations at CSIR-IMTech on June 21, 2017

  • 2